LunaDNA
Uniting for the Common Good
Overview
2018
Healthcare & Pharmaceuticals
HealthTech
B2B
Medium
Low
Balance Sheet
Cash and Cash Equivalents |
$0 |
Investment Securities |
$0 |
Total Investments |
$0 |
Accounts and Notes Receivable |
$0 |
Loans |
$0 |
Property, Plant and Equipment (PP&E) |
$0 |
Property and Equipment |
$0 |
Total Assets |
$51,190 |
Accounts Payable & Accrued Liabilities |
$0 |
Policy Liabilities and Accruals |
$0 |
Deposits |
$0 |
Long Term Debt |
$0 |
Total Liabilities |
$201,334 |
Total Stockholders' Equity |
$-150,144 |
Total Liabilities and Equity |
$51,190 |
Statement of Comprehensive Income Information
Total Revenues |
$39,021 |
Total Interest Income |
$0 |
Costs & Expenses Applicable to Rev |
$63,036 |
Total Interest Expenses |
$0 |
Depreciation and Amortization |
$0 |
Net Income |
$-25,666 |
Earnings Per Share - Basic |
$0.00 |
Earnings Per Share - Diluted |
$0.00 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual